![Mark Cochran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Cochran
Président chez
IFABRIC CORP.
Fortune : 152 547 $ au 31/07/2026
Profil
Mark A. Cochran was the founder of Protein Sciences Corp., founded in 1983, and NeuroVentures Capital LLC, founded in 2000, where the title held was Founding Partner from 2009 to 2020.
Current jobs include Chairman at iFabric Corp.
since 2020, Managing Director at Johns Hopkins Healthcare Solutions, Chief Operating Officer & Director at Neuro-Innovators LLC, and Independent Director at Microbix Biosystems, Inc. since 2002.
Former jobs include Chairman & Interim Chief Executive Officer at Rivanna Pharmaceuticals, Inc., Chief Executive Officer at Blanchette Rockefeller Neurosciences Institute, Director at Acumen Pharmaceuticals, Inc., Director at Transgeneron Therapeutics, Inc., Executive Director at Johns Hopkins Health Plans LLC, Executive Director at Johns Hopkins Medicine, Inc. from 2011 to 2020, Vice President-Business Development at Bayer Pharmaceuticals Corp., and Senior Member at Lumira Capital Investment Management, Inc. Education includes a doctorate from Queen's University, graduate studies at the University of Guelph, and undergraduate studies at the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/02/2026 | 549 277 ( 0,4 % ) | 116 447 $ | 31/07/2026 | |
IFABRIC CORP. 0,03 % | 16/05/2025 | 10 000 ( 0,03 % ) | 36 100 $ | 31/07/2026 |
Postes actifs de Mark Cochran
| Sociétés | Poste | Début |
|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Directeur/Membre du Conseil | 16/10/2002 |
| IFABRIC CORP. | Président | 01/04/2020 |
Neuro-Innovators LLC
 Neuro-Innovators LLC BiotechnologyHealth Technology Operates as a clinical-stage drug company that develops neurorestorative medicine | Directeur des opérations | - |
Anciens postes connus de Mark Cochran
| Sociétés | Poste | Fin |
|---|---|---|
NeuroVentures Capital LLC
 NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital invests in companies located in the United States and Canada. The firm targets companies focused on discovery, development, and marketing of new drugs, therapeutics, medical devices, and central nervous system biotechnology. It provides financing for early and later stage capital requirements. | Fondateur | 31/12/2020 |
Johns Hopkins Medicine, Inc.
 Johns Hopkins Medicine, Inc. Hospital/Nursing ManagementHealth Services Operates a hostpital | Directeur/Membre du Conseil | 01/08/2020 |
Blanchette Rockefeller Neurosciences Institute
 Blanchette Rockefeller Neurosciences Institute BiotechnologyHealth Technology Engages in the research and development of drugs | President | 14/06/2010 |
Transgeneron Therapeutics, Inc.
 Transgeneron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic medicine that promotes tissue regeneration | Directeur/Membre du Conseil | - |
Rivanna Pharmaceuticals, Inc.
 Rivanna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Directeur Général | - |
Formation de Mark Cochran
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Protein Sciences Corp.
 Protein Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Microbix Biosystems, Inc.
 Microbix Biosystems, Inc. BiotechnologyHealth Technology Develops biological products and technologies | Health Technology |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
Rivanna Pharmaceuticals, Inc.
Rivanna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Bayer Pharmaceuticals Corp. | |
Transgeneron Therapeutics, Inc.
Transgeneron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic medicine that promotes tissue regeneration | Health Technology |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuroVentures Capital LLC
NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital invests in companies located in the United States and Canada. The firm targets companies focused on discovery, development, and marketing of new drugs, therapeutics, medical devices, and central nervous system biotechnology. It provides financing for early and later stage capital requirements. | Finance |
University of Guelph
 University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johns Hopkins Medicine, Inc.
Johns Hopkins Medicine, Inc. Hospital/Nursing ManagementHealth Services Operates a hostpital | Health Services |
Blanchette Rockefeller Neurosciences Institute
Blanchette Rockefeller Neurosciences Institute BiotechnologyHealth Technology Engages in the research and development of drugs | Health Technology |
Johns Hopkins Health Plans LLC
 Johns Hopkins Health Plans LLC Packaged SoftwareTechnology Services Provides health analytics software services | Technology Services |
iFabric Corp.
 iFabric Corp. Apparel/FootwearConsumer Non-Durables Manufactures and distributes ladies intimate apparel and accessories | Consumer Non-Durables |
Neuro-Innovators LLC
Neuro-Innovators LLC BiotechnologyHealth Technology Operates as a clinical-stage drug company that develops neurorestorative medicine | Health Technology |
